![Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" / Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /](https://pbs.twimg.com/media/EcfzuqeWoAAgr_H.jpg)
Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /
![What is the Mount Sinai antibody test and how can it provide insight into COVID-19 health status? - YouTube What is the Mount Sinai antibody test and how can it provide insight into COVID-19 health status? - YouTube](https://i.ytimg.com/vi/LkeIS7Hqc1I/hqdefault.jpg)
What is the Mount Sinai antibody test and how can it provide insight into COVID-19 health status? - YouTube
![Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos](https://www.pacientesenbuenasmanos.com/wp-content/uploads/2015/05/cordon-cardo-644x362.jpg)
Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos
Dr. Carlos Cordon-Cardo | Icahn School of Medicine at Mount Sinai, genetics | Dr. Carlos Cordon-Cardo was honored with the 2022 Jacobi Medallion. Dr. Cordon-Cardo is Professor and System Chair of Pathology,
We are live with Dr. Carlos Cordon-Cardo discussing antibody testing for #COVID19. #LiveAtMountSinai | By The Mount Sinai Hospital - Facebook
Mount Sinai Health System on Instagram: “Tune into Facebook Live tonight at 7pm EST, as Dr. Carlo Cordon-Cardo discusses antibody testing at Mount Sinai. #COVID19 #LiveAtMountSinai”
![El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE](https://cope-cdnmed.agilecontent.com/resources/jpg/7/3/1649071127237.jpg)
El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE
![Mount Sinai Health System on Twitter: "Drs. Carlos Cordon-Cardo, Clare Bryce, and Nadeja Tsankova, discuss the late Dr. Mary Fowkes, her legacy, and her impact in fighting the #COVID19 pandemic: https://t.co/ryJmuVyJ4D https://t.co/L9v2hxi5t5" / Mount Sinai Health System on Twitter: "Drs. Carlos Cordon-Cardo, Clare Bryce, and Nadeja Tsankova, discuss the late Dr. Mary Fowkes, her legacy, and her impact in fighting the #COVID19 pandemic: https://t.co/ryJmuVyJ4D https://t.co/L9v2hxi5t5" /](https://pbs.twimg.com/media/EsQ90QFW4AEClhl.jpg)
Mount Sinai Health System on Twitter: "Drs. Carlos Cordon-Cardo, Clare Bryce, and Nadeja Tsankova, discuss the late Dr. Mary Fowkes, her legacy, and her impact in fighting the #COVID19 pandemic: https://t.co/ryJmuVyJ4D https://t.co/L9v2hxi5t5" /
The Mount Sinai Hospital - Dr. Carlos Cordon-Cardo, Chairman of Pathology, and his staff have a message to share. Pathology operates a 24-hour laboratory for #COVID19 testing, allowing us to test hundreds
![Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly | Mount Sinai - New York Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2020/MSHS-Carlos-Newsroom-770x420.jpg)